122 related articles for article (PubMed ID: 35392670)
1. Prognostic Impact of the Preoperative Systemic Inflammation Score in Patients With Pancreatic Ductal Adenocarcinoma.
Iguchi T; Iseda N; Hirose K; Itoh S; Harada N; Ninomiya M; Sugimachi K; Honboh T; Maeda T; Sadanaga N; Matsuura H
Am Surg; 2023 Jun; 89(6):2213-2219. PubMed ID: 35392670
[TBL] [Abstract][Full Text] [Related]
2. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
Fu X; Li T; Dai Y; Li J
BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma.
Pointer DT; Roife D; Powers BD; Murimwa G; Elessawy S; Thompson ZJ; Schell MJ; Hodul PJ; Pimiento JM; Fleming JB; Malafa MP
BMC Cancer; 2020 Aug; 20(1):750. PubMed ID: 32782024
[TBL] [Abstract][Full Text] [Related]
4. Clinical Implication of Pre-operative C-reactive Protein-Albumin Ratio as a Prognostic Factor of Patients With Pancreatic Ductal Adenocarcinoma: A Single-institutional Retrospective Study.
Murakawa M; Yamamoto N; Kamioka Y; Kamiya M; Kobayashi S; Ueno M; Morimoto M; Atsumi Y; Aoyama T; Tamagawa H; Yukawa N; Rino Y; Masuda M; Morinaga S
In Vivo; 2020; 34(1):347-353. PubMed ID: 31882498
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Long-Term Outcome for Patients with Pancreatic Ductal Adenocarcinoma.
Kubota K; Shimizu A; Notake T; Masuo H; Hosoda K; Yasukawa K; Hayashi H; Umemura K; Kamachi A; Goto T; Tomida H; Yamazaki S; Soejima Y
Ann Surg Oncol; 2022 Feb; 29(2):1437-1448. PubMed ID: 34664139
[TBL] [Abstract][Full Text] [Related]
6. The pretherapeutic systemic inflammation score is a prognostic predictor for elderly patients with oesophageal cancer: a case control study.
Huang C; Wang M; Chen L; Wang H; Huang D; Shi J; Zhang W; Tian Y; Zhu Y
BMC Cancer; 2023 Jun; 23(1):505. PubMed ID: 37270496
[TBL] [Abstract][Full Text] [Related]
7. Clinical usefulness of postoperative C-reactive protein/albumin ratio in pancreatic ductal adenocarcinoma.
Arima K; Yamashita YI; Hashimoto D; Nakagawa S; Umezaki N; Yamao T; Tsukamoto M; Kitano Y; Yamamura K; Miyata T; Okabe H; Ishimoto T; Imai K; Chikamoto A; Baba H
Am J Surg; 2018 Jul; 216(1):111-115. PubMed ID: 28859917
[TBL] [Abstract][Full Text] [Related]
8. Preoperative C-reactive protein to albumin ratio is a predictor of survival after pancreatic resection for pancreatic ductal adenocarcinoma.
Ikuta S; Aihara T; Yamanaka N
Asia Pac J Clin Oncol; 2019 Oct; 15(5):e109-e114. PubMed ID: 30632282
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of γ-glutamyltransferase-to-albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery.
Li S; Xu H; Wu C; Wang W; Jin W; Gao H; Li H; Zhang S; Xu J; Zhang W; Xu S; Li T; Ni Q; Yu X; Liu L
Cancer Med; 2019 Feb; 8(2):572-584. PubMed ID: 30632317
[TBL] [Abstract][Full Text] [Related]
10. Does Preoperative Serum Neutrophil to Lymphocyte Ratio (NLR), Platelet to Lymphocyte Ratio (PLR), and Lymphocyte to Monocyte Ratio (LMR) Predict Prognosis Following Radical Surgery for Pancreatic Adenocarcinomas? Results of a Retrospective Study.
Gupta V; Chaudhari V; Shrikhande SV; Bhandare MS
J Gastrointest Cancer; 2022 Sep; 53(3):641-648. PubMed ID: 34406625
[TBL] [Abstract][Full Text] [Related]
11. Systemic inflammation score as a preoperative prognostic factor for patients with pT2-T4 resectable gastric cancer: a retrospective study.
Matsumoto T; Ohki S; Kaneta A; Matsuishi A; Maruyama Y; Yamada L; Tada T; Hanayama H; Watanabe Y; Hayase S; Okayama H; Sakamoto W; Momma T; Saze Z; Kono K
BMC Surg; 2023 Jan; 23(1):8. PubMed ID: 36635689
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of systemic inflammation score in patients who undergo hepatic resection for hepatocellular carcinoma.
Inokuchi S; Itoh S; Yoshizumi T; Morinaga A; Toshima T; Takeishi K; Nagao Y; Harada N; Ikegami T; Shimokawa M; Mori M
Langenbecks Arch Surg; 2021 May; 406(3):773-779. PubMed ID: 33595705
[TBL] [Abstract][Full Text] [Related]
13. Prognostic importance of the preoperative modified systemic inflammation score for patients with gastric cancer.
Lin JX; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Li P
Gastric Cancer; 2019 Mar; 22(2):403-412. PubMed ID: 29982861
[TBL] [Abstract][Full Text] [Related]
14. Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy.
Markus M; Abendroth A; Noureddine R; Paul A; Breitenbuecher S; Virchow I; Schmid KW; Markus P; Schumacher B; Wiesweg M; Wendling J; Mende B; Siveke JT; Schuler M; Kasper S
J Cancer Res Clin Oncol; 2021 Feb; 147(2):579-591. PubMed ID: 32839836
[TBL] [Abstract][Full Text] [Related]
15. A novel combined carbohydrate antigen 19-9 and lymphocyte-to-monocyte ratio score can predict early recurrence of resectable pancreatic ductal adenocarcinoma.
Yugawa K; Maeda T; Nagata S; Sakai A; Taketani K; Yamaguchi S; Konishi K; Hashimoto K
Surg Today; 2023 Oct; 53(10):1199-1208. PubMed ID: 36943449
[TBL] [Abstract][Full Text] [Related]
16. Systemic Inflammation Score as a Novel Prognostic Indicator for Patients Undergoing Video-Assisted Thoracoscopic Surgery Lobectomy for Non-Small-Cell Lung Cancer.
Li S; Zhang W; Yang Z; Li Y; Du H; Che G
J Invest Surg; 2021 Apr; 34(4):428-440. PubMed ID: 31304810
[TBL] [Abstract][Full Text] [Related]
17. Significance of the inflammation-based prognostic score in recurrent pancreatic cancer.
Nakagawa K; Sho M; Akahori T; Nagai M; Nakamura K; Takagi T; Tanaka T; Nishiofuku H; Ohbayashi C; Kichikawa K; Ikeda N
Pancreatology; 2019 Jul; 19(5):722-728. PubMed ID: 31153778
[TBL] [Abstract][Full Text] [Related]
18. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of preoperative PNI and CA19-9 for pancreatic ductal adenocarcinoma: A multi-institutional retrospective study.
Itoh S; Tsujita E; Fukuzawa K; Sugimachi K; Iguchi T; Ninomiya M; Maeda T; Kajiyama K; Adachi E; Uchiyama H; Utsunomiya T; Ikeda Y; Maekawa S; Toshima T; Harada N; Yoshizumi T; Mori M
Pancreatology; 2021 Oct; 21(7):1356-1363. PubMed ID: 34426076
[TBL] [Abstract][Full Text] [Related]
20. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
Kim NH; Kim HJ
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
